NorthWest Biotherapeutics Inc (NWBO)

[iclight]

We at IV understand how trials work and what it takes to run a successful trial, report on the successful trial, and submit the data to the FDA for approval. This trial has none of those. If it was a slam dunk LP would have had the BLA submitted shortly after data lock. They dredged for data knowing that they could keep the charade going without ever submitting anything while NWBO shareholders pay for another LP CDMO. They had plenty of vaccine production capacity with Cognate.

If LP had a choice between making X dollars building out another CDMO or submitting good approvable data and making 10X of course she would have chosen submitting approvable data. She didn’t have a choice because she knows this garbage trial won’t fly with the FDA.